Literature DB >> 29452639

Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53.

Giuseppe Arena1, Madi Yann Cissé2, Samuel Pyrdziak2, Laurent Chatre3, Romain Riscal2, Maryse Fuentes2, Jamie Jon Arnold4, Markus Kastner4, Laurie Gayte2, Christelle Bertrand-Gaday5, Kevin Nay5, Claire Angebault-Prouteau6, Kerren Murray7, Beatrice Chabi5, Christelle Koechlin-Ramonatxo5, Béatrice Orsetti2, Charles Vincent2, François Casas5, Jean-Christophe Marine8, Sandrine Etienne-Manneville7, Florence Bernex9, Anne Lombès10, Craig Eugene Cameron4, Hervé Dubouchaud11, Miria Ricchetti3, Laetitia Karine Linares12, Laurent Le Cam13.   

Abstract

Accumulating evidence indicates that the MDM2 oncoprotein promotes tumorigenesis beyond its canonical negative effects on the p53 tumor suppressor, but these p53-independent functions remain poorly understood. Here, we show that a fraction of endogenous MDM2 is actively imported in mitochondria to control respiration and mitochondrial dynamics independently of p53. Mitochondrial MDM2 represses the transcription of NADH-dehydrogenase 6 (MT-ND6) in vitro and in vivo, impinging on respiratory complex I activity and enhancing mitochondrial ROS production. Recruitment of MDM2 to mitochondria increases during oxidative stress and hypoxia. Accordingly, mice lacking MDM2 in skeletal muscles exhibit higher MT-ND6 levels, enhanced complex I activity, and increased muscular endurance in mild hypoxic conditions. Furthermore, increased mitochondrial MDM2 levels enhance the migratory and invasive properties of cancer cells. Collectively, these data uncover a previously unsuspected function of the MDM2 oncoprotein in mitochondria that play critical roles in skeletal muscle physiology and may contribute to tumor progression.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MDM2; MT-ND6; hypoxia; migration; mitochondria; respiratory complex I

Mesh:

Substances:

Year:  2018        PMID: 29452639     DOI: 10.1016/j.molcel.2018.01.023

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  24 in total

Review 1.  MDM2 and mitochondrial function: One complex intersection.

Authors:  Camila Rubio-Patiño; Andrew Paul Trotta; Jerry Edward Chipuk
Journal:  Biochem Pharmacol       Date:  2018-11-01       Impact factor: 5.858

2.  MDM2 controls gene expression independently of p53 in both normal and cancer cells.

Authors:  Giuseppe Arena; Romain Riscal; Laetitia K Linares; Laurent Le Cam
Journal:  Cell Death Differ       Date:  2018-07-23       Impact factor: 15.828

3.  MDM2 Integrates Cellular Respiration and Apoptotic Signaling through NDUFS1 and the Mitochondrial Network.

Authors:  Rana Elkholi; Ioana Abraham-Enachescu; Andrew P Trotta; Camila Rubio-Patiño; Jarvier N Mohammed; Mark P A Luna-Vargas; Jesse D Gelles; Joshua R Kaminetsky; Madhavika N Serasinghe; Cindy Zou; Sumaira Ali; Gavin P McStay; Cathie M Pfleger; Jerry Edward Chipuk
Journal:  Mol Cell       Date:  2019-03-14       Impact factor: 17.970

4.  Complex I and MDM2: hit me baby one more time.

Authors:  Jerry Edward Chipuk
Journal:  Mol Cell Oncol       Date:  2019-05-10

Review 5.  Disease-Associated Genetic Variation in Human Mitochondrial Protein Import.

Authors:  Emmanuelle Nicolas; Rossella Tricarico; Michelle Savage; Erica A Golemis; Michael J Hall
Journal:  Am J Hum Genet       Date:  2019-05-02       Impact factor: 11.025

Review 6.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

7.  Deficits in the Skeletal Muscle Transcriptome and Mitochondrial Coupling in Progressive Diabetes-Induced CKD Relate to Functional Decline.

Authors:  Daniel C Bittel; Adam J Bittel; Arun S Varadhachary; Terri Pietka; David R Sinacore
Journal:  Diabetes       Date:  2021-02-01       Impact factor: 9.461

8.  Induction of cell cycle arrest and apoptosis by CPUC002 through stabilization of p53 and suppression of STAT3 signaling pathway in multiple myeloma.

Authors:  Yue Zhao; Dongsheng Bai; Jiaying Du; Haochuan Ren; Zhenguo Zhang; Cheng Jiang; Na Lu
Journal:  Cell Biol Toxicol       Date:  2020-10-30       Impact factor: 6.691

9.  Hypermethylation of Hepatic Mitochondrial ND6 Provokes Systemic Insulin Resistance.

Authors:  Ke Cao; Weiqiang Lv; Xueqiang Wang; Shanshan Dong; Xuyun Liu; Tielin Yang; Jie Xu; Mengqi Zeng; Xuan Zou; Daina Zhao; Qingqing Ma; Mu Lin; Jiangang Long; Weijin Zang; Feng Gao; Zhihui Feng; Jiankang Liu
Journal:  Adv Sci (Weinh)       Date:  2021-05-02       Impact factor: 16.806

10.  Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy.

Authors:  Melanie Gartz; Margaret Beatka; Mariah J Prom; Jennifer L Strande; Michael W Lawlor
Journal:  Hum Mol Genet       Date:  2021-11-16       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.